Clinical Trial

Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management

Study acronym: OPTIMOVA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, monocentric study evaluating the presence of sarcopenia prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-06-10; most recent amendment 2026-01-28.
Status change: Recruiting → Active, Not Recruiting 2026-01-28
Status change: Not Yet Recruiting → Recruiting 2023-03-27
Trial Details
NCT Number NCT05415527
Lead Sponsor Institut Bergonié
Conditions Ovarian Carcinoma
Enrollment 25 participants
Start Date 2022-06-11
Primary Completion 2027-06-10 (estimated)
Study Completion 2028-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-29